Comparative effects of raloxifene and al
✍
Robert R. Recker; David Kendler; Christopher P. Recknor; Theodore W. Rooney; E.
📂
Article
📅
2007
🏛
Elsevier Science
🌐
English
⚖ 265 KB
The double-blind, randomized raloxifene alendronate comparison trial was the first study designed to compare two osteoporosis therapies head-to-head for fracture risk reduction. The original protocol planned to treat 3000 postmenopausal women with alendronate 10 mg/day (ALN) or raloxifene 60 mg/day